Sequoia Financial Advisors LLC Reduces Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sequoia Financial Advisors LLC reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 8.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,919 shares of the company’s stock after selling 759 shares during the period. Sequoia Financial Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $681,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of PBH. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth about $84,932,000. Raymond James Financial Inc. purchased a new stake in Prestige Consumer Healthcare in the fourth quarter worth about $42,593,000. Norges Bank purchased a new stake in Prestige Consumer Healthcare in the fourth quarter worth about $40,009,000. Bessemer Group Inc. lifted its holdings in Prestige Consumer Healthcare by 10,053.1% in the fourth quarter. Bessemer Group Inc. now owns 295,050 shares of the company’s stock worth $23,041,000 after buying an additional 292,144 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 1,335.1% in the fourth quarter. Natixis Advisors LLC now owns 209,246 shares of the company’s stock worth $16,340,000 after buying an additional 194,665 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 17th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $80.28 on Wednesday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $64.94 and a fifty-two week high of $90.04. The company has a 50 day simple moving average of $84.16 and a two-hundred day simple moving average of $82.41. The company has a market capitalization of $3.97 billion, a price-to-earnings ratio of 18.71, a P/E/G ratio of 2.40 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The business had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. During the same quarter last year, the firm earned $1.02 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.